NR4A1 and breast cancer: Prior studies showed that young breast cancer patients were more likely to have adverse tumor characteristics (for instance, higher grade, higher fraction in tumor proliferation, higher probability in lymph vascular invasion, and hormone receptor negative) and worse prognosis than older patients (7–10).